PRIMO21.80

Primo Chemicals Limited

· Chemicals
AnnualQuarterly₹ CrorePeersCHEMFABPLASTIBLENMANORGLORDSCHLOKRONOXJAYAGROGNDMCCHPALMcap ₹528 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations155.4141.9134.7140.1144.9140.3
Other Income4.45.34.54.45.65.2
Total Income159.8147.2139.2144.6150.5145.5
Expenses
+ Cost of Materials Consumed86.285.387.981.589.683.0
+ Purchases of Stock-in-Trade6.00.00.011.44.90.0
+ Changes in Inventories-2.00.1-0.11.0-4.22.0
+ Employee Benefit Expense12.912.011.612.011.511.8
+ Finance Costs5.85.54.84.33.93.7
+ Depreciation & Amortisation12.513.113.213.213.013.5
+ Other Expenses28.524.220.020.624.122.7
Total Expenses149.7140.1137.5144.1142.7136.7
EBITDA24.020.415.313.619.020.8
EBIT11.47.32.10.36.07.3
Profit
PBT before Exceptional Items10.17.11.70.47.88.9
+ Exceptional Items0.00.00.0-0.20.00.0
Pretax Income10.17.11.70.27.88.9
+ Current Tax1.81.20.4-0.01.42.1
+ Deferred Tax9.42.8-1.40.61.43.1
Tax Expense11.24.0-1.10.52.75.2
+ Share of Associates & JVs0.71.01.41.41.01.0
Net Income-0.44.14.21.16.14.7
+ Net Income — Continuing Ops-1.13.12.8-0.35.13.6
+ Other Comprehensive Income0.1-0.10.10.2-0.2-0.3
Total Comprehensive Income-0.34.04.31.35.94.3
Per Share
Basic EPS-0.010.170.170.040.250.19
Diluted EPS-0.010.170.170.040.250.19
Other Comprehensive Income — detail
+ Other Comprehensive Income0.1-0.10.10.2-0.2-0.3
+ Items NOT to be Reclassified to P&L0.1-0.20.20.3-0.3-0.5
+ Tax on Items NOT to be Reclassified0.0-0.10.10.1-0.1-0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations-0.010.170.170.040.250.19
Diluted EPS — Continuing Operations-0.010.170.170.040.250.19
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit65.356.647.046.254.655.3
Gross Margin %42.0139.8734.8632.9937.6639.43
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)10.17.11.70.47.88.9
− Exceptional Items (reconciliation)0.00.00.0-0.20.00.0
Net Income Adj (tax-effected)-0.44.14.21.16.14.7
EPS Adj-0.010.170.170.040.250.19
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.002.00
Filed Debt Equity0.000.00
Filed Dscr0.000.01
Filed Iscr0.010.02
Paid Up Equity Capital48.548.548.548.548.548.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.